A phase I study of paclitaxel in combination with SU011248 [sunitinib ] for patients with breast cancer as first-line treatment in the advanced disease setting

Trial Profile

A phase I study of paclitaxel in combination with SU011248 [sunitinib ] for patients with breast cancer as first-line treatment in the advanced disease setting

Completed
Phase of Trial: Phase I

Latest Information Update: 05 Oct 2008

At a glance

  • Drugs Paclitaxel; Sunitinib
  • Indications Advanced breast cancer
  • Focus Adverse reactions
  • Most Recent Events

    • 05 Oct 2008 Planned end date (Aug 2007) added as reported by CT.gov
    • 05 Oct 2008 Status changed from active, no longer recruiting to completed as reported by CT.gov
    • 05 Oct 2008 Actual number of patients (22) added as reported by CY.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top